POST-MARKETING SAFETY STUDIES Authors' reply to Fralick and Kesselheim

被引：0
|
作者：
Spelsberg, Angela [1 ,2 ]
Keil, Ulrich [3 ]
Prugger, Christof [4 ]
机构：
[1] Transparency Int Germany, Working Grp Hlth, Pauwelsstr 30, D-52074 Aachen, Germany
[2] Comprehens Canc Ctr Aachen, Pauwelsstr 30, D-52074 Aachen, Germany
[3] Univ Munster, Inst Epidemiol & Social Med, Albert Schweitzer Campus 1, D-48149 Munster, Germany
[4] Charite, Inst Publ Hlth, Seestr 73, D-13347 Berlin, Germany
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2017年 / 357卷
关键词：
D O I：
10.1136/bmj.j1850
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] POST-MARKETING SURVEILLANCE
    CULLITON, BJ
    WATERFALL, WK
    BRITISH MEDICAL JOURNAL, 1980, 280 (6224): : 1175 - 1176
  • [42] Post-marketing studies of new insulins: sales or science?
    Gale, Edwin A. M.
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [43] Drug utilization studies: Their importance for post-marketing surveillance
    Castro, Lia C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S95 - S96
  • [44] Post-Marketing Pharmacoepidemiology Study Assessing Prolia® Global Safety
    Xue, Fei
    Ma, Haijun
    Xia, Amy
    Jackson, Sam
    Daniels, Andre
    Katz, Leonid
    Katz, Leonid
    Grauer, Andreas
    Critchlow, Cathy
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S227 - S228
  • [45] Sumatriptan and naratriptan tolerability and safety: an update of post-marketing experience
    Welch, KMA
    CEPHALALGIA, 2001, 21 : 25 - 28
  • [46] VEDOLIZUMAB CLINICAL AND POST-MARKETING SAFETY EXPERIENCE OF OPPORTUNISTIC INFECTIONS
    Ng, Siew C.
    Palo, William
    Blake, Aimee
    Rana-Khan, Qasim
    Bhayat, Fatima
    GASTROENTEROLOGY, 2017, 152 (05) : S575 - S576
  • [47] Vedolizumab clinical and post-marketing safety experience of opportunistic infections
    Ng, S. C.
    Palo, W.
    Blake, A.
    Rana-Khan, Q.
    Bhayat, F.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S41 - S41
  • [48] Safety Results of Post-Marketing Surveillance Studies of B/F/TAF in China and South Korea
    Peters, Jami
    Cid-Ruzafa, Javier
    Lang, Markus G.
    Serejo, Margarida
    Omeife, Harmony
    Rubino, Annalisa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 278 - 279
  • [49] POST-MARKETING SAFETY STUDIES OF RECOMBINANT PORCINE FACTOR VIII IN THE UNITED STATES AND EUROPEAN UNION
    Crea, Roberto
    Mauric, Oliver
    Huang, Jui-Fu
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E13 - E13
  • [50] Social Media Listening for Routine Post-Marketing Safety Surveillance
    Gregory E. Powell
    Harry A. Seifert
    Tjark Reblin
    Phil J. Burstein
    James Blowers
    J. Alan Menius
    Jeffery L. Painter
    Michele Thomas
    Carrie E. Pierce
    Harold W. Rodriguez
    John S. Brownstein
    Clark C. Freifeld
    Heidi G. Bell
    Nabarun Dasgupta
    Drug Safety, 2016, 39 : 443 - 454
12345